Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists

J Clin Invest. 2000 Aug;106(4):467-72. doi: 10.1172/JCI10843.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Chromans / therapeutic use
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetes Mellitus, Type 2 / physiopathology
  • Humans
  • Insulin Resistance / genetics
  • Insulin Resistance / physiology*
  • Islets of Langerhans / drug effects
  • Islets of Langerhans / physiology
  • Mice
  • Mice, Knockout
  • Models, Biological
  • Mutation
  • Obesity / drug therapy
  • Obesity / physiopathology
  • Receptors, Cytoplasmic and Nuclear / agonists*
  • Receptors, Cytoplasmic and Nuclear / genetics
  • Receptors, Cytoplasmic and Nuclear / physiology
  • Thiazoles / therapeutic use*
  • Thiazolidinediones*
  • Transcription Factors / agonists*
  • Transcription Factors / genetics
  • Transcription Factors / physiology
  • Troglitazone

Substances

  • Chromans
  • Receptors, Cytoplasmic and Nuclear
  • Thiazoles
  • Thiazolidinediones
  • Transcription Factors
  • Troglitazone